FDANonrulemakingFDA-2026-N-4162
Who commented on this docket
Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) manufactured by Moderna TX Inc.
5 organizations filed 5 public comments on Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments - Safety and Effectiveness of MFLUSIVA (Influenza Vaccine, mRNA) manufactured by Moderna TX Inc., at the Food and Drug Administration. The comment window closed 95d ago.
Organizations
5
Comments
5
RIN
—
Comment window
closed 95d ago
Abstract
OPEN
Commenters (5)
- Adult Vaccine Access Coalitiontrade assoc.1 filing · confidence 85%
- Alliance for mRNA Medicinestrade assoc.1 filing · confidence 85%
- American Pharmacists Association (APhA)trade assoc.1 filing · confidence 97%
- Infectious Diseases Society of Americatrade assoc.1 filing · confidence 85%
- Vasculitis Foundationtrade assoc.1 filing · confidence 85%
Attribution is name-based and imperfect. regulations.gov data is public record.